Allgulander C, Evanoff B
Karolinska Instïtutet, Huddinge, Sweden.
J Psychoactive Drugs. 1990 Oct-Dec;22(4):467-78. doi: 10.1080/02791072.1990.10472221.
Findings of formal and subjective mental health problems among Swedish employees are presented as well as reviews of current Swedish policies on substance abuse and drug screening in the workplace. The focus is on the potential violation of medical confidentiality for employees with legitimate psychoactive drug medications and the lack of evidence linking the detection of various substances with impaired work performance. Data are drawn from a study of a sample of working Swedes, which revealed that approximately 3% reported taking psychoactive medications regularly. This was correlated with increases in long-term sick leave, periods of unemployment, and frequent job changes by both sexes. These workers also scored high for neuroticism, and had high rates of inpatient psychiatric treatment and suicide. With these high rates of formal mental health problems among employees who self-medicate with psychoactive drugs, discriminatory personnel management, including drug screening, jeopardizes confidentiality of treatment and civil rights.
文中呈现了瑞典员工中正式和主观心理健康问题的调查结果，以及对瑞典当前关于职场药物滥用和药物筛查政策的综述。重点在于对合法使用精神活性药物的员工医疗保密可能的侵犯，以及缺乏证据表明检测出各种物质与工作表现受损之间存在关联。数据来自对瑞典在职人员样本的一项研究，该研究表明约3%的人报告定期服用精神活性药物。这与长期病假增加、失业期以及两性频繁更换工作相关。这些员工在神经质方面得分也很高，住院精神治疗和自杀率也很高。鉴于自我使用精神活性药物的员工中正式心理健康问题发生率如此之高，包括药物筛查在内的歧视性人事管理危及治疗保密性和公民权利。
